Riskpilot← Back to searchSign inGet full accessMGH FYSIOTERAPI AS
ASActiveOrg 926357743Sentrums Gården Tvillinggata 3, 1870 ØrjePhysiotherapy activities · NACE 8695Est. 20211 employees
Revenue 2024
NOK 1M
-27% vs 2023
EBITDA margin
6.8%
-57% vs 2023
Equity ratio
42.2%
Financial strength
Net profit 2024
NOK 9K
-86% vs 2023
| Revenue | NOK 1M | -27% |
| EBITDA | NOK 68K | -57% |
| Net profit | NOK 9K | -86% |
| Total assets | NOK 352K | -40% |
| Equity | NOK 149K | +7% |
| Employees | 1 | — |
Legal name
MGH FYSIOTERAPI AS
Org number
926357743
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
8. januar 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Fysioterapi og andre produkter/tjenester som naturlig hører til dette. Selskapet kan delta i andre selskap med lignende virksomhet, samt kjøpe og selge aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Sentrums Gården Tvillinggata 3, 1870 Ørje
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 848 | 916 | 1 390 | 1 010 |
| Staff expenses | −0 | −613 | −673 | −974 | −651 |
| EBITDA | 0 | 27 | 73 | 158 | 68 |
| Depreciation & amort. | −0 | −0 | −39 | −52 | −52 |
| EBIT | 0 | 27 | 34 | 106 | 16 |
| Net financials | 0 | 0 | −0 | −20 | −1 |
| Profit before tax | 0 | 27 | 34 | 85 | 15 |
| Tax | −0 | 5 | 7 | 19 | 6 |
| Net profit | 0 | 22 | 26 | 67 | 9 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30 | 478 | 896 | 583 | 352 |
| Equity | 30 | 47 | 73 | 140 | 149 |
| Long-term debt | 0 | 0 | 24 | 10 | 12 |
| Short-term debt | 0 | 431 | 799 | 434 | 192 |
| Total debt | 0 | 431 | 823 | 444 | 204 |
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
20202024
Equity ratio
42.2%
This company
38.2%
Market median
+10% vs market
20202024
Return on equity
6.2%
This company
18.4%
Market median
-66% vs market
20202024
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20202024
Asset turnover
2.87×
This company
1.12×
Market median
+156% vs market
20202024
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-12-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MG Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MGH FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Greger Hellgren Grimelid | Chief Executive Officer | 0 companies |
| Erik Grimelid | Board of Directors | 0 companies |
| Maria Greger Hellgren | Chairman | 0 companies |